0.07Open0.07Pre Close0 Volume5 Open Interest2.50Strike Price0.00Turnover224.38%IV94.70%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.2087Delta0.3766Gamma18.86Leverage Ratio-0.0045Theta0.0001Rho3.94Eff Leverage0.0010Vega
Connect Biopharma Stock Discussion
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
Price target for this stock is 7$ its undervalued .. sooner it will jump to 2.5 to 3$
No comment yet